Drug Trial Radar · NCT07511361
Study of Efficacy and Safety of Tonlamarsen in Participants With a Recent Hospitalization and a Concurrent Episode of Acute Severe Hypertension
Last checked: Nov 20, 2026Latest source record: Oct 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
140
Planned (sponsor's estimate)
Start
Jun 23, 2026
Primary completion
Dec 2026
Study completion Feb 2027
Sponsor
- Lead sponsor
- Kardigan, Inc.Industry
- Sponsor type
- Industry
- First posted
- Apr 6, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the blood pressure-lowering effect of tonlamarsen in adult participants who were recently hospitalized and concurrently experienced an episode of acute severe hypertension.
Conditions
- Hypertension
- Acute Severe Hypertension
- Hypertensive Emergency
- Hypertensive Urgency
Interventions
TonlamarsenDrug
Tonlamarsen will be administered subcutaneously (under the skin) every 4 weeks during the randomized part of the study
PlaceboDrug
Placebo will be administered subcutaneously (under the skin) every 4 weeks during the randomized part of the study
Primary outcomes
What the sponsor says the trial is designed to measure.
- Part A: To assess variability in clinical and biomarker measures to inform Part B sample-size estimation and study-design assumptionsTime frame: Baseline through Week 12
- Part B: To assess the pharmacodynamic (PD) effect of tonlamarsen on plasma AGT levelsTime frame: Week 4
Locations
13 sites in 1 country. Site status is shown where the registry gives one.
Western Nephrology and Metabolic Bone Disease, PC - Arvada
Arvada, Colorado · Recruiting
Homestead Associates in Research
Homestead, Florida · Recruiting
Progressive Medical Research
Port Orange, Florida · Recruiting
Eagle Clinical Research
Chicago, Illinois · Recruiting
Henry Ford Hospital
Detroit, Michigan · Recruiting
Richmond University Medical Center (RUMC)
Staten Island, New York · Active not recruiting
Research Innovations, LLC
Beavercreek, Ohio · Recruiting
Cleveland Clinic
Cleveland, Ohio · Recruiting
OnSite Clinical Solutions, LLC
Fort Mill, South Carolina · Recruiting
Chattanooga Research & Medicine CHARM
Chattanooga, Tennessee · Recruiting
Laguna Clinical Research Associates
Laredo, Texas · Recruiting
Tapia Internal Medicine Clinic
Paris, Texas · Recruiting
Baylor Scott and White Research Institute - Temple
Temple, Texas · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.